{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:10:48Z","timestamp":1791115848091,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T00:00:00Z","timestamp":1433289600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK57900"],"award-info":[{"award-number":["DK57900"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.cmet.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T11:45:14Z","timestamp":1400154314000},"page":"1050-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["The Role of \u03b2 Cell Glucagon-like Peptide-1 Signaling in Glucose Regulation and Response to Diabetes Drugs"],"prefix":"10.1016","volume":"19","author":[{"given":"Eric\u00a0P.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfor\u00a0G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric\u00a0B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinaz","family":"Mahbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darleen","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Perez-Tilve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Tamarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis\u00a0H.","family":"Philipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris\u00a0A.","family":"Stoffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy\u00a0J.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David\u00a0A.","family":"D\u2019Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2014.04.005_bib1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2014.04.005_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrendo.2011.77","article-title":"GLP-1 and energy balance: an integrated model of short-term and long-term control","volume":"7","author":"Barrera","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cmet.2014.04.005_bib3","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1523\/JNEUROSCI.2212-10.2011","article-title":"Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function","volume":"31","author":"Barrera","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cmet.2014.04.005_bib4","doi-asserted-by":"crossref","first-page":"E334","DOI":"10.1152\/ajpendo.00409.2011","article-title":"Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice","volume":"302","author":"Burmeister","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2014.04.005_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2014.04.005_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12575-009-9021-0","article-title":"A practical guide to rodent islet isolation and assessment","volume":"11","author":"Carter","year":"2009","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.cmet.2014.04.005_bib7","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1210\/en.2011-1385","article-title":"What if gut hormones aren\u2019t really hormones: DPP-4 inhibition and local action of GLP-1 in the gastrointestinal tract","volume":"152","author":"D\u2019Alessio","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2014.04.005_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cmet.2010.04.007","article-title":"GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis","volume":"11","author":"De Marinis","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2014.04.005_bib9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diab.44.9.1126","article-title":"Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects","volume":"44","author":"Deacon","year":"1995","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.cmet.2014.04.005_bib10","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2337\/dcS13-2015","article-title":"GLP-1 effects on islets: hormonal, neuronal, or paracrine?","volume":"36","author":"Donath","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2014.04.005_bib11","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2014.04.005_bib12","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2014.04.005_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-59745-471-1_18","article-title":"Inducible Cre mice","volume":"530","author":"Feil","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cmet.2014.04.005_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2337\/diabetes.47.4.646","article-title":"Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene","volume":"47","author":"Flamez","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2014.04.005_bib15","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2014.04.005_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00125-005-1705-7","article-title":"Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors","volume":"48","author":"Holst","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2014.04.005_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/361362a0","article-title":"Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)","volume":"361","author":"Holz","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2014.04.005_bib18","article-title":"Assessment of beta cell viability","volume":"Chapter 6","author":"Jayaraman","year":"2011","journal-title":"Curr. Protoc. Cytom."},{"key":"10.1016\/j.cmet.2014.04.005_bib19","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1210\/en.2012-1358","article-title":"Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4","volume":"153","author":"Jessen","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2014.04.005_bib20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2337\/db12-1013","article-title":"\u03b2-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion","volume":"62","author":"Kaihara","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2014.04.005_bib21","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/edrv.20.6.0385","article-title":"The glucagon-like peptides","volume":"20","author":"Kieffer","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cmet.2014.04.005_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4161\/isl.2.3.11396","article-title":"Intraislet production of GLP-1 by activation of prohormone convertase 1\/3 in pancreatic \u03b1-cells in mouse models of \u00df-cell regeneration","volume":"2","author":"Kilimnik","year":"2010","journal-title":"Islets"},{"key":"10.1016\/j.cmet.2014.04.005_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI42497","article-title":"Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice","volume":"122","author":"Lamont","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2014.04.005_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI7456","article-title":"Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats","volume":"105","author":"Nie","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2014.04.005_bib25","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/en.2008-1221","article-title":"Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms","volume":"150","author":"R\u00fcttimann","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2014.04.005_bib26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2337\/db09-1253","article-title":"Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes","volume":"59","author":"Salehi","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2014.04.005_bib27","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2337\/db07-1824","article-title":"Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake","volume":"57","author":"Sandoval","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2014.04.005_bib28","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1172\/JCI1349","article-title":"Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans","volume":"101","author":"Schirra","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"issue":"Suppl 1","key":"10.1016\/j.cmet.2014.04.005_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1463-1326.2011.01453.x","article-title":"Brain glucose sensing and neural regulation of insulin and glucagon secretion","volume":"13","author":"Thorens","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2014.04.005_bib30","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/en.2006-0153","article-title":"Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats","volume":"148","author":"Vahl","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2014.04.005_bib31","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsb\u00f8ll","year":"2003","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2014.04.005_bib32","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1210\/en.2011-0286","article-title":"Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice","volume":"152","author":"Waget","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2014.04.005_bib33","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/db10-0624","article-title":"Conditional gene targeting in mouse pancreatic \u00df-Cells: analysis of ectopic Cre transgene expression in the brain","volume":"59","author":"Wicksteed","year":"2010","journal-title":"Diabetes"}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413114001697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413114001697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:25:33Z","timestamp":1761549933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413114001697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1550413114001697"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2014.04.005","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of \u03b2 Cell Glucagon-like Peptide-1 Signaling in Glucose Regulation and Response to Diabetes Drugs","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}